OMCL Stock Recent News
OMCL LATEST HEADLINES
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Central Med Automation Service.
Omnicell, Inc. (NASDAQ:OMCL ) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET Company Participants Kathleen Nemeth - Senior Vice President Randall Lipps - Founder, Chairman, President and CEO Nchacha Etta - Executive Vice President and CFO Conference Call Participants Stan Berenshteyn - Wells Fargo Scott Schoenhaus - KeyBanc Matt Hewitt - Craig-Hallum Capital Group David Larsen - BTIG Bill Sutherland - The Benchmark Company Anna Kruszenski - Barclays Allen Lutz - Bank of America Jessica Tassan - Piper Sandler Anne Samuel - JPMorgan Operator Good morning and thank you for standing by. My name is Aaron, and I will be your conference operator for today.
Omnicell's (OMCL) Q2 results outpace expectations despite a challenging customer environment.
Omnicell (OMCL) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.57 per share a year ago.
Omnicell (OMCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Omnicell (OMCL) remains a key player in automating and modernizing global medication management infrastructure.
A robust Advanced Services portfolio and strategic restructuring initiatives bode well for Omnicell (OMCL).
With the EnlivenHealth platform, Omnicell (OMCL) is gaining momentum with cross-selling and up-selling communication solutions to existing customers.
Omnicell (OMCL) outpaces expectations in the first quarter of 2024 in a challenging customer environment.
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the BofA Securities 2024 Health Care Conference.